Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review
Kumar Rishabh, Soham Khadilkar, Aviral Kumar, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2561-2561
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 364
miRNAs in Cancer (Review of Literature)
Beata Smolarz, Adam Durczyński, Hanna Romanowicz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2805-2805
Open Access | Times Cited: 169
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 111
Xanthohumol from Hop: Hope for cancer prevention and treatment
Sosmitha Girisa, Queen Saikia, Devivasha Bordoloi, et al.
IUBMB Life (2021) Vol. 73, Iss. 8, pp. 1016-1044
Open Access | Times Cited: 59
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
Milad Ashrafizadeh, Sepideh Mirzaei, Kiavash Hushmandi, et al.
Life Sciences (2021) Vol. 278, pp. 119649-119649
Closed Access | Times Cited: 55
Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
Krishan Kumar Thakur, Aviral Kumar, Kishore Banik, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 12, pp. 7938-7965
Closed Access | Times Cited: 50
Gene regulation by antisense transcription: A focus on neurological and cancer diseases
Sajad Najafi, Shing Cheng Tan, Pourya Raee, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112265-112265
Open Access | Times Cited: 44
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.
Life Sciences (2021) Vol. 288, pp. 119948-119948
Closed Access | Times Cited: 42
An overview of the pharmacological activities of scopoletin against different chronic diseases
Parama Dey, Sosmitha Girisa, Elina Khatoon, et al.
Pharmacological Research (2022) Vol. 179, pp. 106202-106202
Closed Access | Times Cited: 34
Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions
Giuseppe Gattuso, Salvatore Crimi, Alessandro Lavoro, et al.
Non-Coding RNA (2022) Vol. 8, Iss. 4, pp. 60-60
Open Access | Times Cited: 30
The World of Oral Cancer and Its Risk Factors Viewed from the Aspect of MicroRNA Expression Patterns
Ovidiu Aghiorghiesei, Oana Zănoagă, Andreea Nuțu, et al.
Genes (2022) Vol. 13, Iss. 4, pp. 594-594
Open Access | Times Cited: 29
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
Aviral Kumar, Bandari BharathwajChetty, Mukesh Kumar Manickasamy, et al.
Pharmacological Research (2024) Vol. 203, pp. 107167-107167
Open Access | Times Cited: 7
Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review
Elika Verma, Aviral Kumar, Uzini Devi Daimary, et al.
Journal of Functional Foods (2021) Vol. 86, pp. 104660-104660
Open Access | Times Cited: 38
The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC)
Shika Hanif Malgundkar, Yahya Tamimi
Human Genetics (2024) Vol. 143, Iss. 2, pp. 107-124
Closed Access | Times Cited: 5
RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics
Guruprasadh Swaminathan, Aisha Shigna, Aviral Kumar, et al.
Frontiers in Nanotechnology (2021) Vol. 3
Open Access | Times Cited: 30
Noncoding RNAs in oral cancer
Jaikrishna Balakittnen, Chameera Ekanayake Weeramange, Daniel F. Wallace, et al.
Wiley Interdisciplinary Reviews - RNA (2022) Vol. 14, Iss. 3
Open Access | Times Cited: 20
MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways
Vinod Kumar Verma, Syed Sultan Beevi, Rekha A. Nair, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
A new perspective on diagnostic strategies concerning the potential of saliva-based miRNA signatures in oral cancer
Monisha Prasad, Ramya Sekar, M. Priya, et al.
Diagnostic Pathology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Molecular Mechanisms in the Carcinogenesis of Oral Squamous Cell Carcinoma: A Literature Review
Laertty Garcia de Sousa Cabral, Isabela Mancini Martins, Ellen Paim de Abreu Paulo, et al.
Biomolecules (2025) Vol. 15, Iss. 5, pp. 621-621
Open Access
Nuclear receptors in oral cancer-Emerging players in tumorigenesis
Shailendra Kumar Gangwar, Aviral Kumar, Sandra Jose, et al.
Cancer Letters (2022) Vol. 536, pp. 215666-215666
Closed Access | Times Cited: 17
Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment
Anjana Sajeev, Mangala Hegde, Uzini Devi Daimary, et al.
Phytomedicine (2022) Vol. 105, pp. 154369-154369
Closed Access | Times Cited: 17
The role of exo‐miRNA in diagnosis and treatment of cancers, focusing on effective miRNAs in colorectal cancer
H.H.K. Al-Shukri, Sana Ali, Karam Akram Al‐Akkam, et al.
Cell Biology International (2024) Vol. 48, Iss. 3, pp. 280-289
Closed Access | Times Cited: 3
Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models
Aviral Kumar, Amarnath Singam, Guruprasadh Swaminathan, et al.
Nanoscale (2021) Vol. 14, Iss. 2, pp. 492-505
Closed Access | Times Cited: 23
Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer
Ahmed S. Doghish, Shereen Saeid Elshaer, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155027-155027
Closed Access | Times Cited: 9
The potential role of miR‐1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco‐suppressor microRNA?
Mohammad Reza Kalhori, Masoud Soleimani, Ehsan Arefian, et al.
Journal of Cellular Biochemistry (2021) Vol. 123, Iss. 3, pp. 506-531
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top